We are live on ! Find out more
BL

Bleichroeder LP Portfolio holdings

AUM $559M
1-Year Est. Return 83.7%
This Fund
S&P 500
This Quarter Est. Return
+8.56%
1 Year Est. Return
+83.7%
3 Year Est. Return
+202.15%
5 Year Est. Return
+208.71%
10 Year Est. Return
–
AUM
$559M
AUM Growth
-$19.6M
Cap. Flow
+$14.4M
Cap. Flow %
2.58%
Top 10 Hldgs %
77.52%
Holding
87
New
6
Increased
9
Reduced
8
Closed
9

Top Buys

Rank Stock Value
1
LIQT icon
LiqTech
LIQT
+$5.92M
2
COGT icon
Cogent Biosciences
COGT
+$3.5M
3
CUE icon
Cue Biopharma
CUE
+$3.24M
4
SPIR icon
Spire Global
SPIR
+$2.51M
5
DTIL icon
Precision BioSciences
DTIL
+$2.5M

Top Sells

Rank Stock Value
1
LIN icon
Linde
LIN
+$4.07M
2
JPM icon
JPMorgan Chase
JPM
+$1.49M
3
POCI icon
Precision Optics
POCI
+$1.19M
4
RTX icon
RTX Corp
RTX
+$1.16M
5
FLNT
Fluent
FLNT
+$831K

Sector Composition

Rank Sector Weight
1 Miscellaneous 41.42%
2 Industrials 22.38%
3 Healthcare 17.16%
4 Technology 6.03%
5 Materials 5.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MDXH icon
26
MDxHealth
MDXH
$68.8M
$3.03M 0.54%
7,378,333
– –
IRD
27
Opus Genetics
IRD
$307M
$3.03M 0.54%
736,842
– –
TV icon
28
Televisa
TV
$1.45B
$2.79M 0.5%
1,030,000
– –
BRFH icon
29
Barfresh Food Group
BRFH
$20.4M
$2.78M 0.5%
1,390,758
– –
DMAC icon
30
DiaMedica Therapeutics
DMAC
$345M
$2.69M 0.48%
382,317
– –
ROC
31
Rank One Computing Corp
ROC
$82M
$2.63M 0.47%
500,000
– –
SPIR icon
32
Spire Global
SPIR
$535M
$2.51M 0.45%
+135,000
New +$2.51M
IPWR icon
33
Ideal Power
IPWR
$77.1M
$2.14M 0.38%
400,000
+100,000
+33% +$509K
NMTC icon
34
NeuroOne Medical Technologies
NMTC
$16.1M
$2.03M 0.36%
666,666
-1
-0% -$4
CRIS icon
35
Curis
CRIS
$3.61M
$1.99M 0.36%
190,116
– –
RVMDW icon
36
Revolution Medicines Inc Warrant
RVMDW
$129M
$1.88M 0.34%
200,000
– –
PROF
37
Profound Medical
PROF
$250M
$1.69M 0.3%
254,753
– –
RNXT icon
38
RenovoRx
RNXT
$75.4M
$1.63M 0.29%
1,666,098
– –
MODD icon
39
Modular Medical
MODD
$28.2M
$1.52M 0.27%
336,986
+150,000
+80% +$683K
VENU
40
Venu Holding Corp
VENU
$114M
$1.36M 0.24%
600,000
– –
TLPH icon
41
Talphera
TLPH
$62.3M
$1.35M 0.24%
1,307,787
– –
QTI
42
QT Imaging Holdings
QTI
$45.2M
$1.29M 0.23%
316,667
+150,001
+90% +$834K
LLYVK icon
43
Liberty Live Group Series C
LLYVK
$9.53B
$1.17M 0.21%
13,802
– –
DETX
44
Liberty Defense Holdings
DETX
$19.7M
$1.12M 0.2%
+277,777
New +$1.17M
RNTX
45
Rein Therapeutics
RNTX
$65.7M
$1.04M 0.19%
+1,000,000
New +$1.21M
OWLT icon
46
Owlet
OWLT
$146M
$987K 0.18%
172,000
– –
SINT icon
47
SiNtx Technologies
SINT
$10M
$978K 0.18%
+523,013
New +$1.21M
CLRB icon
48
Cellectar Biosciences
CLRB
$23.9M
$803K 0.14%
288,679
+188,679
+189% +$528K
MAIA icon
49
MAIA Biotechnology
MAIA
$80.9M
$720K 0.13%
500,000
– –
FEAM icon
50
5E Advanced Materials
FEAM
$67.7M
$638K 0.11%
458,774
-41,226
-8% -$68.7K
1
2
3 4

Similar funds

NFW
Noble Family Wealth Clearwater, Florida $559M AUM 24.35% 1-Year Est. Return
IRC
Investors Research Corp Atlanta, Georgia $559M AUM 21.55% 1-Year Est. Return
SCM
Soros Capital Management New York $559M AUM 171.77% 1-Year Est. Return
PHC
Palidye Holdings (Caymans) Grand Cayman, Cayman Islands $559M AUM 1.08% 1-Year Est. Return
EPM
Equitec Proprietary Markets Chicago, Illinois $559M AUM 230.29% 1-Year Est. Return
BCM
Brasada Capital Management Houston, Texas $558M AUM 21.68% 1-Year Est. Return
FAM
Frontier Asset Management Sheridan, Wyoming $558M AUM 22.41% 1-Year Est. Return
WDG
Wealth Dimensions Group Cincinnati, Ohio $558M AUM 20.63% 1-Year Est. Return

Bleichroeder LP's Q2 2026 Portfolio in Review

As of Q2 2026, Bleichroeder LP held 87 positions worth $559M, down 3.4% from $579M the previous quarter. Its ten largest holdings account for 78% of the portfolio.

Bleichroeder LP's Q2 2026 filing shows 6 new, 9 increased, 8 reduced and 9 closed positions. Its largest new stake was Cogent Biosciences: 100,000 shares worth $3.87M. The largest sale was Linde, an estimated $4.07M.

By sector, the portfolio is most concentrated in Miscellaneous at 41% of assets, down from 44% a quarter earlier, followed by Industrials and Healthcare.

  • Bleichroeder LP's largest Q2 2026 buy was Cogent Biosciences: 100,000 shares worth $3.87M.
  • Bleichroeder LP added most to LiqTech in Q2 2026, an estimated $5.92M increase.
  • Bleichroeder LP's biggest Q2 2026 reduction was Linde, cutting an estimated $4.07M.
  • Bleichroeder LP fully exited Precision Optics in Q2 2026, selling an estimated $1.19M.
  • Bleichroeder LP's ten largest holdings make up 78% of its $559M portfolio in Q2 2026.
  • Bleichroeder LP opened 6 new positions and closed 9 in Q2 2026.
  • Bleichroeder LP's portfolio value fell 3.4% quarter-over-quarter to $559M.

Based on Bleichroeder LP's 13F filing for Q2 2026, filed 13 Aug 2026.